Braintree, Massachusetts
United States
20
2025-09-18
The entities that hold a legal rights for patent applications filed by inventor Visser Michael Scott:
Michael Scott Visser from Braintree, US has applied for patents for these inventions. The list has both pending applications and granted patents:
3-(1-OXO-5-(PIPERIDIN-4-YL)ISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND USES THEREOF
#2 | 2023-03-023-(5-HYDROXY-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND USES THEREOF
#3 | 2022-05-123-(1-OXO-5-(PIPERIDIN-4-YL)ISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND USES THEREOF
#4 | 2021-10-073-(1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND USES THEREOF
#5 | 2020-08-20Protein kinase C inhibitors and methods of their use
#6 | 2020-07-233-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof
#7 | 2020-01-163-(5-hydroxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof
#8 | 2019-12-053-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof
#9 | 2019-11-283-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof
#10 | 2019-07-04Protein kinase C inhibitors and methods of their use
#11 | 2019-02-283-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof
#12 | 2018-06-28PROTEIN KINASE C INHIBITORS AND METHODS OF THEIR USE
#13 | 2016-12-01Protein kinase C inhibitors and methods of their use
#14 | 2016-02-18Protein kinase C inhibitors and methods of their use
#15 | 2015-03-19Compounds for inhibiting the interaction of BCL2 with binding partners
#16 | 2014-12-04COMPOUNDS FOR INHIBITING THE INTERACTION OF BCL2 WITH BINDING PARTNERS
#17 | 2014-12-04COMPOUNDS FOR INHIBITING THE INTERACTION OF BCL2 WITH BINDING PARTNERS
#18 | 2014-11-27COMPOUNDS FOR INHIBITING THE INTERACTION OF BCL2 WITH BINDING PARTNERS
#19 | 2014-11-20Compounds for inhibiting the interaction of BCL2 with binding partners
#20 | 2012-06-28Sulfonamides as inhibitors of Bcl-2 family proteins for the treatments of cancer
976435 ⎘